Latest Content

Enhertu Regimen Improves Responses in High-Risk HER2+ Breast Cancer

May 7th 2025, 3:00pm

By Spencer Feldman

Article

Treatment with an Enhertu regimen significantly improved pathologic complete responses for patients with high-risk HER2-positive early-stage breast cancer.

Breast Cancer Survivor Reflects on 30 Years, Urges Informed Decisions

May 7th 2025, 1:00pm

By Connie Pombo

Article

After 30 years with breast cancer, I urge others to pause, reflect and choose care based on long-term wellbeing, not fear or pressure.

Fighting for Patients, Processes and Education

May 6th 2025, 9:00pm

By Dr. Theresa Medina

Article

I would like to nominate Ashley Tullio, RN, for the Extraordinary Healer Award for Oncology Nursing.

Immune Therapy Expands Melanoma Treatment to More Patients

May 6th 2025, 8:00pm

By Dr. Douglas B. Johnson

Video

Immune therapy is generally safer than chemotherapy, allowing more patients with melanoma and other conditions like heart or lung issues receive treatment.

The Importance of Personalized Treatment Approaches for Urologic Cancers

May 6th 2025, 7:00pm

By Ryan Scott

Article

Dr. Armine Smith discusses the importance of personalized therapeutic approaches for the treatment of urologic cancers, such as bladder or kidney cancer.

Nurse’s Big Personality Makes Cancer Treatment More Bearable.

May 6th 2025, 5:00pm

By Kelly Irvin

Article

She wore a variety of bright sneakers and occasionally did a cha-cha-cha in them. Her laughter was contagious. Patients smiled. The other nurses smiled.

Givinostat Wins U.S. FDA Fast Track Designation for Patients With PV

May 6th 2025, 4:00pm

By Ryan Scott

Article

Treatment with givinostat has received fast track designation from the United States Food and Drug Administration for patients with polycythemia vera.

First Patient With Advanced Lung Cancer Dosed With Peluntamig Combo

May 6th 2025, 3:00pm

By Spencer Feldman

Article

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer and neuroendocrine carcinomas.

Delving Into the Braftovi Plus Erbitux FDA Approval for BRAF+ mCRC

May 6th 2025, 1:00pm

By Ryan Scott

Article

Dr. Cathy Eng discusses data that led to the FDA approval of Braftovi and Erbitux plus chemo for metastatic colorectal cancer with a BRAF V600E mutation.

A Staunch Advocate For Radiation Oncology Nursing and Compassionate Care

May 5th 2025, 9:00pm

By ALLISON OCHOCKI, B.S.N., RN

Article

Everyone knows someone who has been affected by cancer.

A Personalized Approach to Bladder Preservation in Urologic Cancers

May 5th 2025, 8:00pm

By Dr. Armine Smith

Video

Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment plan.

Mitigating Peripheral Neuropathy During Cancer Treatment

May 5th 2025, 7:00pm

By Dr. Shirley D'Sa

Video

Dr. Shirley D'Sa discusses the importance of catching peripheral neuropathy in patients with Waldenström macroglobulinemia early on and how to treat it.

My Lung Cancer Journey: With Family, Friends and Medical Professionals

May 5th 2025, 5:00pm

By Sue McCarthy

Article

The strongest connections I’ve made are with others who have also been through their own cancer journeys.

AI Tool Predicts Pediatric Glioma Recurrence With Up to 89% Accuracy

May 5th 2025, 4:00pm

By Spencer Feldman

Article

An AI model using serial brain scans predicted glioma recurrence in children with up to 89% accuracy, outperforming single-image methods.

Exploring a Patient Case: Biomarker Testing After Progression and Discussing Treatment Choices With Your Care Team

May 5th 2025, 3:04pm

By Virginia Kaklamani, MD, DSc

Video

Panelists discuss how to communicate genomic testing results to patients and make shared treatment decisions, particularly when multiple targeted therapy options are available for patients with ESR1 and PIK3CA mutations.